BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26224798)

  • 1. Circulating C-Reactive Protein and Breast Cancer Risk-Systematic Literature Review and Meta-analysis of Prospective Cohort Studies.
    Chan DS; Bandera EV; Greenwood DC; Norat T
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1439-49. PubMed ID: 26224798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
    Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
    Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
    Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study.
    Dossus L; Jimenez-Corona A; Romieu I; Boutron-Ruault MC; Boutten A; Dupré T; Fagherazzi G; Clavel-Chapelon F; Mesrine S
    Cancer Causes Control; 2014 Apr; 25(4):533-9. PubMed ID: 24504436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
    Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies.
    Chen Y; Liu L; Zhou Q; Imam MU; Cai J; Wang Y; Qi M; Sun P; Ping Z; Fu X
    BMC Public Health; 2017 Dec; 17(1):936. PubMed ID: 29216920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
    Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
    Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
    Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
    Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies.
    Touvier M; Fassier P; His M; Norat T; Chan DS; Blacher J; Hercberg S; Galan P; Druesne-Pecollo N; Latino-Martel P
    Br J Nutr; 2015 Aug; 114(3):347-57. PubMed ID: 26173770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
    Pierce BL; Neuhouser ML; Wener MH; Bernstein L; Baumgartner RN; Ballard-Barbash R; Gilliland FD; Baumgartner KB; Sorensen B; McTiernan A; Ulrich CM
    Breast Cancer Res Treat; 2009 Mar; 114(1):155-67. PubMed ID: 18401703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis.
    Wang J; Lee IM; Tworoger SS; Buring JE; Ridker PM; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1199-206. PubMed ID: 25994740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian Diabetes, Obesity and Lifestyle Study.
    Wiseman AJ; Lynch BM; Cameron AJ; Dunstan DW
    Cancer Causes Control; 2014 Oct; 25(10):1309-19. PubMed ID: 25053405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors.
    George SM; Neuhouser ML; Mayne ST; Irwin ML; Albanes D; Gail MH; Alfano CM; Bernstein L; McTiernan A; Reedy J; Smith AW; Ulrich CM; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2220-8. PubMed ID: 20716617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis.
    Ye J; Jia J; Dong S; Zhang C; Yu S; Li L; Mao C; Wang D; Chen J; Yuan G
    Eur J Cancer Prev; 2014 May; 23(3):158-65. PubMed ID: 23929213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
    Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
    Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
    Tsilidis KK; Branchini C; Guallar E; Helzlsouer KJ; Erlinger TP; Platz EA
    Int J Cancer; 2008 Sep; 123(5):1133-40. PubMed ID: 18528865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RE: Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Wion-Barbot N; Wion D
    J Natl Cancer Inst; 2016 Jan; 108(1):djv320. PubMed ID: 26547928
    [No Abstract]   [Full Text] [Related]  

  • 18. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis.
    Heikkilä K; Harris R; Lowe G; Rumley A; Yarnell J; Gallacher J; Ben-Shlomo Y; Ebrahim S; Lawlor DA
    Cancer Causes Control; 2009 Feb; 20(1):15-26. PubMed ID: 18704713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.
    Macis D; Guerrieri-Gonzaga A; Gandini S
    Int J Epidemiol; 2014 Aug; 43(4):1226-36. PubMed ID: 24737805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There Any Role for Serum Cathepsin S and CRP Levels on Prognostic Information in Breast Cancer? The Swedish Mammography Cohort.
    Basu S; Harris H; Larsson A; Vasson MP; Wolk A
    Antioxid Redox Signal; 2015 Dec; 23(16):1298-302. PubMed ID: 26079659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.